<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">752677</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2021.752677</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Regeneration of Subcutaneous Cartilage in a Swine Model Using Autologous Auricular Chondrocytes and Electrospun Nanofiber Membranes Under Conditions of Varying Gelatin/PCL Ratios</article-title>
<alt-title alt-title-type="left-running-head">Zheng et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Electrospun Scaffolds Regulate Subcutaneous Chondrogenesis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Rui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiaoyun</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xue</surname>
<given-names>Jixin</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/685391/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yao</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Gaoyang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Bingcheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Mengjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ruhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shen</surname>
<given-names>Zhengyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1395902/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Guangdong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/764429/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Plastic and Reconstructive Surgery, Shanghai 9th People&#x2019;s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai Stem Cell Institute</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Dermatology, Shanghai 9th People&#x2019;s Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Cosmetic Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children&#x2019;s Hospital of Wenzhou Medical University</institution>, <addr-line>Wenzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>National Tissue Engineering Center of China</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Research Institute of Plastic Surgery, Weifang Medical College</institution>, <addr-line>Weifang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1143279/overview">Laura Creemers</ext-link>, University Medical Center Utrecht, Netherlands</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/321143/overview">Zigang Ge</ext-link>, Peking University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/126674/overview">Feng-Huei Lin</ext-link>, National Taiwan University, Taiwan</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Guangdong Zhou, <email>guangdongzhou@126.com</email>; Yu Liu, <email>yuliu1211@163.com</email>; Zhengyu Shen, <email>neuronszy@sina.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Tissue Engineering and Regenerative Medicine, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>752677</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Zheng, Wang, Xue, Yao, Wu, Yi, Hou, Xu, Zhang, Chen, Shen, Liu and Zhou.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Zheng, Wang, Xue, Yao, Wu, Yi, Hou, Xu, Zhang, Chen, Shen, Liu and Zhou</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>The scarcity of ideal biocompatible scaffolds makes the regeneration of cartilage in the subcutaneous environment of large animals difficult. We have previously reported the successful regeneration of good-quality cartilage in a nude mouse model using the electrospun gelatin/polycaprolactone (GT/PCL) nanofiber membranes. The GT/PCL ratios were varied to generate different sets of membranes to conduct the experiments. However, it is unknown whether these GT/PCL membranes can support the process of cartilage regeneration in an immunocompetent large animal model. We seeded swine auricular chondrocytes onto different GT/PCL nanofiber membranes (GT:PCL &#x3d; 30:70, 50:50, and 70:30) under the sandwich cell-seeding mode. Prior to subcutaneously implanting the samples into an autologous host, they were cultured <italic>in&#x20;vitro</italic> over a period of 2&#xa0;weeks. The results revealed that the nanofiber membranes with different GT/PCL ratios could support the process of subcutaneous cartilage regeneration in an autologous swine model. The maximum extent of homogeneity in the cartilage tissues was achieved when the G5P5 (GT: PC &#x3d; 50: 50) group was used for the regeneration of cartilage. The formed homogeneous cartilage tissues were characterized by the maximum cartilage formation ratio. The extents of the ingrowth of the fibrous tissues realized and the extents of infiltration of inflammatory cells achieved were found to be the minimum in this case. Quantitative analyses were conducted to determine the wet weight, cartilage-specific extracellular matrix content, and Young&#x2019;s modulus. The results indicated that the optimal extent of cartilage formation was observed in the G5P5 group. These results indicated that the GT/PCL nanofiber membranes could serve as a potential scaffold for supporting subcutaneous cartilage regeneration under clinical settings. An optimum GT/PCL ratio can promote cartilage formation.</p>
</abstract>
<kwd-group>
<kwd>cartilage regeneration</kwd>
<kwd>large animal</kwd>
<kwd>subcutaneous environment</kwd>
<kwd>electrospun nanofiber membrane</kwd>
<kwd>inflammatory reaction</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Cartilage defects in the subcutaneous environment (such as ear, nose, and trachea) due to congenital disease (microtia), cancer removal, or trauma are very common in plastic and reconstructive surgery (<xref ref-type="bibr" rid="B33">Wiggenhauser et&#x20;al., 2017</xref>). The defects can significantly alter the appearance, psychological status, and physiological function of the patients. Traditional methods followed to repair these defects involve the implantation of a pre-shaped prosthetic graft made from silastic or high-density polyethylene (Medpor<sup>&#xae;</sup>) or the transplantation of sculpted autologous cartilage (usually harvested from the rib, nasal septum, or auricle) (<xref ref-type="bibr" rid="B6">Brent, 1999</xref>; <xref ref-type="bibr" rid="B3">Bateman and Jones, 2000</xref>; <xref ref-type="bibr" rid="B20">Kim, et&#x20;al., 2011</xref>). The poor bioactivity of the prosthetic grafts can potentially result in extrusion and infection, while the use of grafts developed from autologous cartilage can cause severe donor-site morbidity. The process is characterized by a prolonged operative time, and the success of the process is heavily dependent on the skill of the surgeon. An ideal cartilaginous substitute with a pre-designed shape and characterized by the minimum donor-site morbidity can be developed using tissue engineering technology. This can help address the problems faced when the traditional cartilage reconstructive approaches are followed (<xref ref-type="bibr" rid="B29">Sterodimas et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B4">Bichara et&#x20;al., 2012</xref>). Recently, good progress has been made in the field of cartilage engineering. Materials and methods that can be used for nasal, auricular, and tracheal reconstruction have been developed. Some of the materials developed have entered the stage of proof-of-feasibility clinical trials (<xref ref-type="bibr" rid="B37">Zang et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B12">Fulco et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B5">Bichara et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B27">Pomerantseva et&#x20;al., 2016</xref>). However, a method to achieve reliable and stable cartilage regeneration in the subcutaneous environment is yet to be developed. This is because the clinical outcomes vary from patient to patient. The fluctuations in the clinical outcomes can be potentially attributed to the inflammatory reactions triggered by the use of the engineered cartilaginous grafts for subcutaneous implantation.</p>
<p>The subcutaneous environment is different from the environment of the immune privileged articular tissue (<xref ref-type="bibr" rid="B15">Huang et&#x20;al., 2016</xref>). The subcutaneous environment is characterized by a high extent of immune activities and the absence of endogenous chondrogenic cues (<xref ref-type="bibr" rid="B25">Nayyer et&#x20;al., 2012</xref>). The implanted engineered cartilaginous grafts face acute immune attack, which may significantly hinder the process of cartilage formation, resulting in the absorption of the implanted grafts. This phenomenon is particularly observed when the grafts engineered from polymeric scaffolds such as polyglycolic acid/polylactic acid (PGA/PLA), whose degradation products promote antigenicity, are used (<xref ref-type="bibr" rid="B2">Asawa et&#x20;al., 2012</xref>). We have previously proposed a long (&#x3e;8&#xa0;weeks) <italic>in&#x20;vitro</italic> pre-culture scheme that can be used to implant the engineered grafts when the scaffolds have been significantly degraded. The extent of postimplantation inflammation realized could be decreased, and stable subcutaneous cartilage could be formed in an autologous preclinical goat model using the PGA/PLA-engineered cartilage (<xref ref-type="bibr" rid="B21">Liu et&#x20;al., 2016</xref>). However, the process of prolonged <italic>in&#x20;vitro</italic> culture results in an increase in the grafting time. This can potentially increase the risk of contamination. Under these conditions, the cost of executing the method also increases. It is important to identify or develop a scaffold characterized by low immunogenicity to support the formation of stable subcutaneous cartilage and reduce the time taken for the <italic>in&#x20;vitro</italic> pre-culture process.</p>
<p>Electrospun nanofibers can mimic microscopic aspects of the extracellular matrix (ECM) and help to establish a tissue-specific microenvironment that maintains and regulates cell behavior and function (<xref ref-type="bibr" rid="B19">Kanani and Bahrami, 2010</xref>; <xref ref-type="bibr" rid="B28">Qian et&#x20;al., 2018</xref>). Gelatin (GT) and polycaprolactone (PCL) exhibit significantly low immunogenicity. GT is a biosafety scaffold that exhibits good biocompatibility but poor mechanical strength. The scaffold is characterized by a rapid degradation time. PCL is a synthetic polymer characterized by a good mechanical strength and prolonged degradation time. It can be used to complement the disadvantages of using GT. Electrospun nanofibers fabricated by blending GT with PCL exhibit excellent physiochemical, biomechanical, and biocompatible properties. These nanofibers have been widely used as scaffolds to conduct <italic>in&#x20;vitro</italic> cellular studies with a variety of tissues (<xref ref-type="bibr" rid="B7">Chong et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B17">Ji et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B18">Jiang et&#x20;al., 2017</xref>). There are a few papers that report the feasibility of engineering a three-dimensional (3D) tissue using the electrospun GT/PCL membranes. The lack of information can be potentially attributed to the limitations posed by the thicknesses of the materials. There is also a dearth of information in the field of 3D tissue regeneration in large animals used in preclinical trials. We have previously reported the ability of the electrospun GT/PCL membranes to support cartilage formation following a sandwich strategy using nude mouse models (<xref ref-type="bibr" rid="B35">Xue et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>). The results revealed that a combination of GT and PCL (high GT and low PCL contents; aGT: PCL &#x3d; 70:30) could be used to achieve cartilage formation in nude mice. Successful regeneration of human ear-shaped cartilage could be achieved (<xref ref-type="bibr" rid="B38">Zheng, et&#x20;al., 2014</xref>).</p>
<p>However, it is unknown if the formation of cartilage can be realized using this scaffold in a large animal model used in preclinical trials. It should also be tested if the optimized GT/PCL ratio used for cartilage regeneration in a nude mouse can be effectively used for cartilage regeneration in a preclinical large animal model. It has been reported that the electrospun nanofibrous membranes function as anti-inflammatory barriers that help alleviate inflammatory reactions (<xref ref-type="bibr" rid="B31">Wang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B23">Luo et&#x20;al., 2016</xref>). We also studied if the electrospun GT/PCL membranes can be used to alleviate inflammatory reactions to improve the quality of the 3D cartilage regenerated in a large animal&#x20;model.</p>
<p>We used the electrospun GT/PCL membranes with different GT/PCL ratios to construct cartilage-like tissues (<italic>in&#x20;vitro</italic>) using the previously established sandwich strategy to predict the potential of using the scaffold in the field of clinical translation. Following this, the regenerated cartilage-like tissue was implanted into an autologous subcutaneous environment in a swine model to evaluate the feasibility of forming subcutaneous cartilage and study the effect of different GT/PCL ratios on the cartilage regeneration process in a large preclinical model. The results presented herein provide direct experimental evidence required to promote the clinical translation of cartilage regeneration using electrospun GT/PCL membranes.</p>
</sec>
<sec id="s2">
<title>2 Materials and Methods</title>
<sec id="s2-1">
<title>2.1 Isolation and Expansion of Chondrocytes</title>
<p>A total of five adult swine (16&#xa0;weeks old; Shanghai Jiagan Biological Technology Co., Ltd., Shanghai, China) were used for the studies. All animals received humane care according to the guidelines laid down in 2006 by the National Ministry of Science in the &#x201c;Guide for Care of Laboratory Animals.&#x201d; The animal care and experiment committee of the Shanghai Jiao Tong University School of Medicine approved the animal studies conducted by us. A biopsy of the auricular cartilage (2.0 &#xd7; 1.0&#xa0;cm) obtained from the autologous swine sample was conducted under conditions of endotracheal anesthesia. The surrounding fibrous tissue and perichondrium were removed, and the cartilage biopsy was minced into fragments (dimension: 1.0&#xa0;mm<sup>3</sup>). The samples were pretreated with 0.25% trypsin (HyClone, Logan, UT, USA) at 37&#xb0;C over a period of 30&#xa0;min. Following this, the sample was washed with phosphate-buffered solution (PBS). Subsequently, the sample was digested with 0.3% collagenase NB4 (Worthington Biochemical Corp., Freehold, NJ, United&#x20;States) for 8&#xa0;h at 37&#xb0;C. The isolated cells were cultured and expanded using Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM, Gibco BRL, Grand Island, NY, United&#x20;States) containing 10% fetal bovine serum (FBS, HyClone, Logan, UT, United&#x20;States), penicillin (100&#xa0;U/ml), and streptomycin (100&#xa0;&#x3bc;g/ml), following previously reported protocols (<xref ref-type="bibr" rid="B10">Feng et&#x20;al., 2012</xref>). Chondrocytes in passage two (P2) were harvested for scaffold seeding.</p>
</sec>
<sec id="s2-2">
<title>2.2 Preparation of Scaffolds Under Conditions of Varying GT/PCL Ratios</title>
<p>As previously described (<xref ref-type="bibr" rid="B35">Xue et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>), GT/PCL membranes with GT:PCL ratios (by weight) of 70:30 (G7P3), 50:50 (G5P5), and 30:70 (G3P7) were fabricated and trimmed to form round-shaped samples (diameter: 9&#xa0;mm). The samples were irradiated with UV light over a period of 30&#xa0;min to obtain sterilized samples. Prior to conducting the cell seeding process, the samples were lyophilized using a vacuum free-drier (VirTis BenchTop 6.6; SP Industries, Gardiner, NY, United&#x20;States).</p>
</sec>
<sec id="s2-3">
<title>2.3 Mechanical Analysis of the Scaffolds</title>
<p>The mechanical properties of the electrospun fibrous membranes in their dry state were determined using a tabletop uniaxial material testing machine (H5K-S, Hounsfield, United&#x20;Kingdom). Rectangular specimens (10 &#xd7; 50&#xa0;mm) were stretched at a constant cross-head speed of 10&#xa0;mm/min (<xref ref-type="bibr" rid="B10">Feng et&#x20;al., 2012</xref>). At least eight samples were tested for each type of membrane. The tensile strength, Young&#x2019;s modulus, and strain at break for all the groups were calculated and analyzed based on the stress&#x2013;strain&#x20;curve.</p>
</sec>
<sec id="s2-4">
<title>2.4 Scanning Electron Microscopy</title>
<p>For the cell-loaded group, 2.0 &#xd7; 10<sup>5</sup> chondrocytes in 1.0&#xa0;ml of the medium (DMEM with 10% FBS) were evenly dropped onto the GT/PCL membrane and incubated at 37&#xb0;C under conditions of 95% humidity and 5% CO<sub>2</sub> (incubation time: 24&#xa0;h). The cell-loaded or non-loaded membranes were rinsed with PBS, fixed in 0.05% glutaraldehyde at 4&#xb0;C overnight, dehydrated through a graded series of ethanol, critical-point dried, and analyzed using the SEM technique (JEOL-6380LV, Tokyo, Japan). The extent of adhesion achieved and the distribution of the chondrocytes on the membranes were studied following previously reported methods (<xref ref-type="bibr" rid="B35">Xue et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>).</p>
</sec>
<sec id="s2-5">
<title>2.5 Macrophages and GT/PCL Membranes</title>
<sec id="s2-5-1">
<title>2.5.1 Macrophage Seeding</title>
<p>GT/PCL membranes were punched into 14-mm discs to fit 24-well plates. The samples were disinfected with 70% ethanol and washed thoroughly with PBS prior to conducting the cell seeding process. Raw 264.7 macrophages at 80% confluence were detached using trypsin. Subsequently, the cells were centrifuged and resuspended in the medium. The seeding density of the macrophage on the scaffolds was 5&#x20;&#xd7; 10<sup>5</sup>&#xa0;cells/cm<sup>2</sup>. The cell-seeded scaffolds were transferred to an incubator and cultured at 37&#xb0;C. The medium was changed every 2&#xa0;days. The samples were harvested at predesignated time points for further analysis.</p>
</sec>
<sec id="s2-5-2">
<title>2.5.2 Confocal Microscopy</title>
<p>The biocompatibility of the macrophages with the GT/PCL membranes was analyzed using the confocal microscope (Leica, TCS SP8 STED 3X, Wetzlar, Germany) technique. On day 2, the cell-seeded scaffolds were harvested and fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 (time: 5&#xa0;min). Subsequently, the treated samples were incubated with rhodamine-conjugated phalloidin for 30&#xa0;min at room temperature in the dark. DAPI was used to stain the nuclei. The samples were imaged using a confocal microscope.</p>
</sec>
<sec id="s2-5-3">
<title>2.5.3&#x20;Enzyme-Linked Immunosorbent Assay</title>
<p>The supernatant obtained when the macrophages were cultured was collected after 24&#xa0;h of incubation. The supernatant was used to conduct ELISA. Mouse IL-6 ELISA Kit, Mouse TNF-&#x3b1; ELISA Kit, and Human/Mouse Arginase 1/ARG1 ELISA Kit (all ELISA kits: MultiSciences, Hangzhou, China) were used for the studies. The protocols outlined by the manufacturers were followed. The macrophages directly seeded inside the 14-mm dishes were used as the negative controls. The macrophages treated with a solution of lipopolysaccharide (LPS; 2.5&#xa0;&#x3bc;g/ml) were used as the positive controls. Cell culture experiments were performed in groups of four, and the experiments were repeated three times (<xref ref-type="bibr" rid="B39">Zheng et&#x20;al., 2021</xref>).</p>
</sec>
<sec id="s2-5-4">
<title>2.5.4 Histological Analysis</title>
<p>Paraformaldehyde fixed macrophage-seeded GT/PCL membranes (14&#xa0;mm diameter) were embedded in paraffin at days 2, 4, and 6. Sections were stained with hematoxylin and eosin (H&#x26;E) (<xref ref-type="bibr" rid="B32">Wang et&#x20;al., 2021</xref>).</p>
</sec>
</sec>
<sec id="s2-6">
<title>2.6 Preparation of Chondrocyte-Scaffold Constructs</title>
<p>The chondrocyte-GT/PCL constructs were prepared following the sandwich approach reported in the literature (<xref ref-type="bibr" rid="B13">Gong et&#x20;al., 2011</xref>). Briefly, a chondrocyte suspension (5&#xa0;&#x3bc;l) with a cell density of 100&#x20;&#xd7; 10<sup>6</sup>&#xa0;cells/ml was seeded onto one slice of the GT/PCL membrane. The process was followed by stacking another slice of the GT/PCL membrane onto the previous one. Subsequently, it was seeded with the same number of chondrocytes until a 10-layer membrane stack was formed. The constructs were incubated for 2.5&#xa0;h (37&#xb0;C, 95% humidity, 5% CO<sub>2</sub>) to allow the cells to get attached. Following this, a pre-warmed medium (DMEM with 10% FBS) was applied gently to cover the constructs. The medium was changed twice per week. After 2&#xa0;weeks, the constructs were either subjected to the conditions of gross, histological, and immunohistochemical analyses or subcutaneously implanted into autologous swine members to conduct <italic>in vivo</italic>&#x20;tests.</p>
</sec>
<sec id="s2-7">
<title>2.7 Subcutaneous Implantation</title>
<p>After 2&#x20;weeks of <italic>in&#x20;vitro</italic> culture, the chondrocyte-GT/PCL constructs were implanted subcutaneously into autologous swine (time: 3 and 6&#xa0;weeks). Under conditions of endotracheal anesthesia, individual subcutaneous pockets were created in the abdominal area. One construct was implanted into each pocket. The incisions were closed, and the animals were allowed to recover. Penicillin was injected intramuscularly over a period of 3&#xa0;days, commencing on the first-day post operation.</p>
</sec>
<sec id="s2-8">
<title>2.8 Gross Evaluation</title>
<p>The <italic>in vivo</italic> samples were harvested after 3 and 6&#xa0;weeks had passed post subcutaneous implantation. The surrounding fibrous tissues were carefully removed, and the appearance (color and texture) and wet weight of the samples were studied.</p>
</sec>
<sec id="s2-9">
<title>2.9 Histological and Immunohistochemical Analyses</title>
<p>All the constructs targeted for histological analysis were bisected post gross evaluation. One-half of each construct was stored at &#x2212;80&#xb0;C for biochemical assays. The other half was fixed with 4% paraformaldehyde (fixing time: 24&#xa0;h), embedded in paraffin, sectioned into slices (diameter: 5&#xa0;&#x3bc;m), and mounted on glass slides. Sections were stained with hematoxylin and eosin (H&#x26;E) or Safranin O following standard protocols. Type II collagen, CD3, and CD68 were detected following the principles of immunohistochemistry. Mouse anti-human type II collagen monoclonal antibody (1:200 in PBS, Santa Cruz, CA, United&#x20;States), mouse anti-human CD3 monoclonal antibody (1:200 in PBS, Santa Cruz, CA, United&#x20;States), and mouse anti-human CD68 monoclonal antibody (1:200 in PBS, Santa Cruz, CA, United&#x20;States) were used to study all the samples. Horseradish peroxidase (HRP)-conjugated anti-mouse antibody (1:200 in PBS, Santa Cruz, CA, United&#x20;States) was then applied as a secondary antibody. Color development was achieved using diaminobenzidine tetrahydrochloride (DAB, Santa Cruz, CA, United&#x20;States), and cell nuclei were counterstained with hematoxylin according to previously established techniques (<xref ref-type="bibr" rid="B21">Liu et&#x20;al., 2016</xref>).</p>
</sec>
<sec id="s2-10">
<title>2.10 Biomechanical and Biochemical Analyses</title>
<p>Young&#x2019;s moduli of thatic compression; biomechanical analyzer, Instron-5542, Canton, MA, United&#x20;States) (Yan, et e 3- and 6-weeks specimens were detected and analyzed following previously established methods (<xref ref-type="bibr" rid="B36">Yan, et&#x20;al., 2009</xref>). After mechanical testing, the samples were collected and minced for biochemical analysis. The sulfated glycosaminoglycan (GAG) content was determined by conducting the dimethylmethylene blue chloride (DMMB, Sigma-Aldrich, St. Louis, MO, United&#x20;States) assay, and the results were expressed in mg/g wet weight (<xref ref-type="bibr" rid="B9">Farndale et&#x20;al., 1982</xref>). The content of type II collagen was determined following an enzyme-linked immunosorbent assay approach (<xref ref-type="bibr" rid="B40">Zhou et&#x20;al., 2018</xref>). Five samples were analyzed in each group, and all assays were performed in duplicate as per the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2-11">
<title>2.11&#x20;Semi-Quantification Analysis</title>
<p>The areas corresponding to cartilage formation, undegraded scaffold, and inflammatory infiltration were quantified using the software used for picture analysis (ImageJ, National Institutes of Health (NIH), Bethesda, MD, United&#x20;States). The corresponding regions were studied by analyzing the specific histological features. Subsequently, the total area in each structure was summed, and the corresponding areas of each parameter were divided by the total area of the samples.</p>
</sec>
<sec id="s2-12">
<title>2.12 Statistical Analysis</title>
<p>The quantitative data were recorded as mean&#x20;&#xb1; standard deviation (SD). The differences among the groups in wet weight, GAG content, type II collagen content, and Young&#x2019;s moduli (for the 3- and 6-week specimens) were analyzed by conducting the one-way ANOVA tests (<italic>n</italic>&#x20;&#x3d; 5). The area proportions corresponding to the cartilage tissue, undegraded scaffold, and inflammatory infiltration recorded for the 3-week specimens were also analyzed by conducting the one-way ANOVA tests (<italic>n</italic>&#x20;&#x3d; 5). A <italic>p</italic>-value less than 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Influence of the GT/PCL Ratio on the Basic Properties of the Scaffolds and Chondrocyte Compatibility</title>
<p>We first examined the gross appearance, microstructure, and chondrocyte compatibility of the GT/PCL membranes. The results revealed that the GT/PCL membranes characterized by varying GT/PCL ratios appeared ivory-white. The diameters of the membranes were calculated to be 9&#xa0;mm (gross observation; <xref ref-type="fig" rid="F1">Figures 1A&#x2013;C</xref>). Analysis of the SEM images revealed that the diameter of the fiber decreased slightly with an increase in the GT content (<xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>). Additional mechanical analyses were conducted. Significant differences in the mechanical properties were observed among the three groups of the GT/PCL membranes. The tensile strengths and Young&#x2019;s moduli of the membranes increased significantly while the strain at break decreased with an increase in the PCL content (<xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). The chondrocytes adhered and spread well on the membranes in all groups after 24&#xa0;h of cell seeding. This indicated that all the GT/PCL membranes exhibited good biocompatibility with the chondrocytes (<xref ref-type="fig" rid="F1">Figures 1G&#x2013;I</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Gross view, microstructure, and cell compatibility of GT/PCL membranes. The membranes are easily trimmed into round shape, and no visible differences are observed among different GT/PCL content groups <bold>(A&#x2013;C)</bold>. SEM shows a similar fibrous microstructure while the fiber diameter slightly decreased with GT content <bold>(D&#x2013;F),</bold> and chondrocytes can spread well on the surfaces of all the membranes after 24&#xa0;h of cell seeding <bold>(G&#x2013;I)</bold>.</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Influence of the GT/PCL Ratio on the Biocompatibility, Immunomodulatory Behavior, and Cell Distribution of the Macrophages (<italic>in&#x20;vitro</italic>)</title>
<p>Analysis of the confocal microscopy images revealed that the macrophages grew well on the membranes with different GT/PCL contents after 24&#xa0;h of incubation (<xref ref-type="sec" rid="s12">Supplementary Figures S2A&#x2013;C</xref>). No significant differences in TNF-&#x3b1; (M1 marker), IL-6 (M1 marker), and Arg-1 (M2 marker) were observed among the three groups, indicating that the GT/PCL membranes characterized by varying GT/PCL ratios exhibited low immunogenicity. The results also revealed the difficulty in realizing the polarization of the macrophages (<xref ref-type="sec" rid="s12">Supplementary Figures S2D&#x2013;F</xref>). Results from histological analyses revealed that the macrophages grew well on the surface of the GT/PCL membranes. It was also observed that the macrophages could not infiltrate the membranes even after 2 and 4&#xa0;days (<xref ref-type="sec" rid="s12">Supplementary Figures S3A&#x2013;F</xref>). This indicated that the membranes provided a physical barrier that blocked macrophage infiltration. When G5P5 and G3P7 were studied, it was observed that the effect of the cell barrier could be observed at day 6 (<xref ref-type="sec" rid="s12">Supplementary Figures S3H,I</xref>). For the G7P3 group, a small number of the macrophages could be detected inside the membranes at day 6 (<xref ref-type="sec" rid="s12">Supplementary Figure S3G</xref>). This indicated that the <bold>barrier effect</bold> started to deteriorate under these conditions. This could be attributed to the rapid degradation of the G7P3 membranes.</p>
</sec>
<sec id="s3-3">
<title>3.3 Influence of the GT/PCL Ratio on the Process of <italic>in&#x20;vitro</italic> Cartilage Formation</title>
<p>Before conducting the process of subcutaneous implantation, the samples generated <italic>in&#x20;vitro</italic> were studied for cartilage formation following the processes of gross observation and histological staining. It was observed that the chondrocyte-GT/PCL constructs in all groups retained their original shapes and sizes when they were subjected to conditions of <italic>in&#x20;vitro</italic> culture over 2&#xa0;weeks (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;C</xref>). Histologically, all the samples formed cartilage-like tissues with typical lacuna-like structures. The type II collagen could be positively stained (<xref ref-type="fig" rid="F2">Figures 2D&#x2013;I</xref>). The extent of ECM deposition observed in the cartilage present in the G7P3 group was higher than the extent of cartilage ECM depositions observed in the other two groups. This was revealed by analyzing the staining patterns of type II collagen (<xref ref-type="fig" rid="F2">Figure&#x20;2G</xref>). In addition, the samples belonging to the G7P3 group exhibited better neocartilage integration. These samples did not exhibit the lamellar structure. Relatively loose lamellar structures separated by the GT/PCL membranes were observed in the G3P7 group. The results obtained from the <italic>in&#x20;vitro</italic> studies indicated that the GT/PCL membranes characterized by low PCL contents could promote the formation of cartilage <italic>in&#x20;vitro</italic>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Gross view and histological examination of engineered tissues at 2&#xa0;weeks <italic>in&#x20;vitro</italic>. All the samples basically maintain the cylinder shape after cell seeding and retain the original shape after <italic>in&#x20;vitro</italic> implantation <bold>(A&#x2013;C)</bold>. The samples in all groups form cartilage-like tissue with typical lacuna structure and positive staining of type II collagen <bold>(D&#x2013;I)</bold>. In the G7P3 group <bold>(G)</bold>, the samples show obviously positive staining of type II collagen than the other two groups <bold>(H,I)</bold>.</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g002.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Influence of the GT/PCL Ratio on the Early Stage of Subcutaneous Cartilage Formation</title>
<p>We studied the early stages of cartilage formation <italic>in vivo</italic> using the GT/PCL membranes under conditions of varying GT/PCL ratios. We used a swine model for our studies. After 3&#xa0;weeks of subcutaneous implantation (in autologous swine), the samples belonging to the G7P3 group shrank significantly and appeared yellow. The texture of the samples was soft (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Under the same conditions, the samples belonging to the G5P5 and G3P7 groups retained the original sizes and formed cartilage-like tissues that were hard and elastic (<xref ref-type="fig" rid="F3">Figures 3B,C</xref>). The wet weight, Young&#x2019;s moduli, GAG content, and Collagen &#x2161; content recorded for the G7P3 group were lower than those recorded for the G5P5 and G3P7 groups (<xref ref-type="fig" rid="F3">Figures 3D&#x2013;G</xref>). No significant difference in the data was observed for the G5P5 and G3P7 groups.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Gross view and quantitative analysis of engineered tissues at 3&#xa0;weeks <italic>in vivo</italic>. The samples in G7P3 remarkably shrink and show yellowish appearance <bold>(A)</bold> while the samples in G5P5 and G3P7 groups retained the original size and show ivory-white appearance <bold>(B,C)</bold>. Quantitative analysis demonstrates that the samples in the G7P3 group show lower values in wet weight, Young&#x2019;s modulus, total GAG, and Collagen &#x2161; than those in G5P5 and G3P7 groups <bold>(D&#x2013;G)</bold>. No obvious differences are observed in terms of wet weight, Young&#x2019;s modulus, total GAG, and Collagen &#x2161; between the G5P5 group and the G3P7 group <bold>(D&#x2013;G)</bold>. &#x2a;Indicating significant differences (&#x2a;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01).</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g003.tif"/>
</fig>
<p>Results obtained by conducting histological evaluations agreed well with the results obtained from gross view and quantitative analyses. Samples belonging to the G7P3 group formed sparse cartilage islands surrounded by abundant inflammatory cells and fibrous tissues (continuous lamellar scaffolds were absent), indicating that low PCL content was not favorable for cartilage regeneration in a large animal model (<xref ref-type="fig" rid="F4">Figures 4A&#x2013;E</xref>). The results did not reflect the results obtained by conducting <italic>in&#x20;vitro</italic> studies. The results also did not agree well with the results obtained by studying a nude mouse model (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>) (<xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>). The cartilage formed in the interior regions of the samples belonging to the G5P5 and G3P7 groups were more homogenous than those formed in the interior regions of the samples belonging to the G7P3 group. These cartilage were characterized by a typical lacuna-like structure. Positive staining of GAG and type II collagen (exception: some undegraded lamellar scaffolds) was observed in the neocartilage (<xref ref-type="fig" rid="F4">Figures 4F&#x2013;O</xref>). The formation of homogenous cartilage with fine interlayer integration was observed at the edge of the samples belonging to the G5P5 group. Significant levels of invasion of the fibrous tissues or inflammatory cells toward the interior of the sample were not observed (<xref ref-type="fig" rid="F4">Figure&#x20;4G</xref>). The extent of tissue aggregation observed at the edge of the samples belonging to the G3P7 group was relatively lower than the extent of tissue integration observed in the G5P5 group. A significant amount of the fibrous tissues invaded the interior of the sample along with the lamellar scaffolds (<xref ref-type="fig" rid="F4">Figure&#x20;4L</xref>). These results indicated that a significantly high PCL content was not favorable for cartilage regeneration in a large animal&#x20;model.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Histological examination and semiquantitative analysis in engineered tissues at 3&#xa0;weeks <italic>in vivo</italic>. In the G7P3 group, the samples show sparse cartilage islands surrounded by abundant inflammatory cells, fibrous tissue, and discontinuous laminar scaffolds <bold>(A&#x2013;E)</bold>. In the G5P5 and G3P7 groups, relatively homogenous cartilage is observed in the interior regions (blue box) of the samples with typical lacuna structure and positive staining of GAG and type II collagen <bold>(H&#x2013;J,M&#x2013;O)</bold>, and continuous undegraded lamellar scaffolds (marked with &#x2a;) are still observed among neocartilage <bold>(H,M)</bold>. At the edge of the samples (red box), the G5P5 group shows relatively homogenous cartilage formation with fine interlayer integration and no obvious fibrous tissue invades toward the interior of the sample <bold>(G)</bold>. In the G3P7 group, relatively inferior tissue integration is observed at the edge of the samples and obvious fibrous tissue invades toward the interior of the sample along with the interlayer gap <bold>(L)</bold>. The semiquantitative analysis shows significant differences in area percentage of cartilage tissue, fibrous tissue, and undegraded scaffolds among the three groups <bold>(P&#x2013;R)</bold>. &#x2a;Indicating significant differences (&#x2a;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01).</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g004.tif"/>
</fig>
<p>The results obtained from semiquantitative analyses revealed significant differences among the three groups in terms of the area percentages corresponding to the cartilage tissues, fibrous tissues, and undegraded scaffolds (<xref ref-type="fig" rid="F4">Figures 4P&#x2013;R</xref>). According to the statistical results, the samples belonging to the G5P5 group presented the maximum percentage for the cartilage tissue area, the minimum percentage for the fibrous tissue area, and a moderate percentage for the undegraded scaffold area. This indicated that an optimum GT to PCL ratio helped the extent of cartilage regeneration achieved. It also helped reduce the extent of invasion of the fibrous tissue in a large animal&#x20;model.</p>
</sec>
<sec id="s3-5">
<title>3.5 Influence of the GT/PCL Ratio on the Maturation of the Subcutaneous Cartilage</title>
<p>We then evaluated the <italic>in vivo</italic> fate of the engineered cartilage after a long period (6 weeks) following subcutaneous implantation. Analysis of <xref ref-type="fig" rid="F5">Figure&#x20;5</xref> reveals that the size of the 6-week-old specimen belonging to the G7P3 group is much smaller than the size of the 6-week-old specimen belonging to the G5P5 and G3P7 groups (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>). The wet weight, Young&#x2019;s moduli, GAG contents, and collagen II contents recorded for the samples belonging to the G7P3 groups were significantly lower than those recorded for the samples belonging to the G5P5 and G3P7 groups (<xref ref-type="fig" rid="F5">Figures 5D&#x2013;G</xref>). It was also observed that Young&#x2019;s moduli and collagen II contents recorded for the samples belonging to the G5P5 group were higher than those recorded for the samples belonging to the G3P7 group (<xref ref-type="fig" rid="F5">Figures 5E,G</xref>). The results from histological analyses further confirmed the above observation. The samples belonging to the G7P3 group formed cartilage islands isolated by fibrous tissue (<xref ref-type="fig" rid="F6">Figures 6A&#x2013;E</xref>), and the samples belonging to the G5P5 and G3P7 groups formed continuous and homogenous cartilage in the interior of the samples (<xref ref-type="fig" rid="F6">Figures 6H&#x2013;J</xref>). The extent of distribution of the cartilage and fibrous tissues realized in the samples was consistent with the distribution of the tissues realized after 3 weeks. Satisfactory levels of cartilage integration were observed in the edge regions in the samples of the G5P5 group (<xref ref-type="fig" rid="F6">Figure&#x20;6G</xref>). A small extent of fibrous tissue invasion was observed in this case. Poor tissue integration and significantly high levels of fibrous tissue invasion were observed at the edges of the samples belonging to the G3P7 group (<xref ref-type="fig" rid="F6">Figure&#x20;6L</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Gross view and quantitative analysis of engineered tissues at 6&#xa0;weeks <italic>in vivo</italic>. The samples in the G7P3 group remarkably shrink <bold>(A)</bold> while the samples in the G5P5 and G3P7 groups retain the original size <bold>(B,C)</bold>. Quantitative analysis reveals that the samples in the G7P3 group show lower values in wet weight, total GAG, Collagen &#x2161;, and Young&#x2019;s modulus <bold>(D&#x2013;G)</bold> than those in the G5P5 and G3P7 groups. The samples in the G5P5 group show higher Young&#x2019;s modulus and collagen II content compared to those in the G3P7 group <bold>(E,G)</bold>. &#x2a;Indicating significant differences (&#x2a;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01).</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g005.tif"/>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Histological examination and semiquantitative analysis in engineered tissues at 6&#xa0;weeks <italic>in vivo</italic>. Histological evaluation shows that the samples in the G7P3 group form cartilage islands isolated by fibrous tissue and discontinuous lamellar scaffolds <bold>(A&#x2013;E)</bold> while the samples in the G5P5 and G3P7 groups form continuous and homogenous cartilage with continuous undegraded lamellar scaffolds in the interior area of the samples <bold>(H&#x2013;J,M&#x2013;O)</bold>. The edge regions in the G5P5 group <bold>(G)</bold> show relatively satisfactory cartilage integration with little fibrous tissue invasion while the edge regions in the G3P7 group present relatively inferior tissue integration (separated by undegraded lamellar scaffolds &#x2a;) with obvious fibrous tissue invasion <bold>(L)</bold>. The semiquantitative analysis shows significant differences in area percentage of cartilage tissue, fibrous tissue, and undegraded scaffolds among the three groups <bold>(P&#x2013;R)</bold>.</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g006.tif"/>
</fig>
<p>Results obtained by conducting semiquantitative analyses revealed significant differences in terms of the area percentages corresponding to cartilage tissues, fibrous tissues, and undegraded scaffolds among the three groups. The G5P5 group exhibited the best extent of cartilage formation. The formation of the minimum amount of fibrous tissues and the presence of a moderate scaffold residual were also observed in this case. This indicated that an optimum GT to PCL ratio promoted cartilage regeneration in a large animal model (<xref ref-type="fig" rid="F6">Figures 6P&#x2013;R</xref>). Noticeably, the area percentages corresponding to the cartilage tissues, fibrous tissues, and undegraded scaffolds recorded for the 6-week samples were consistent with the results obtained for the 3-week samples. Significant differences among the groups were not observed, indicating that the results obtained for the 3- and 6-week-old samples could predict long-term results.</p>
</sec>
<sec id="s3-6">
<title>3.6 Influence of the GT/PCL Ratio on the Inflammatory Reaction (<italic>in vivo</italic>)</title>
<p>The 3-week specimens were further subjected to conditions of immunohistochemical staining using CD3&#x20;[T-cell marker (<xref ref-type="bibr" rid="B30">van Dongen et&#x20;al., 1988</xref>)] and CD68 [monocyte/macrophage markers (<xref ref-type="bibr" rid="B14">Holness and Simmons, 1993</xref>)] to determine the status of the subcutaneous postimplantation inflammation. The results revealed that after 3&#xa0;weeks of subcutaneous implantation (in autologous swine), the CD3- and CD68-positive cells presented highly consistent distribution in all the samples. The samples in different groups presented different distribution trends for CD3- and CD68-positive cells. A large number of CD3- and CD68-positive cells were observed throughout the samples surrounding the sparse cartilage islands and scaffold pieces (<xref ref-type="fig" rid="F7">Figures 7A&#x2013;C</xref>, <xref ref-type="fig" rid="F8">Figures 8A&#x2013;C</xref>) in the specimens belonging to the G7P3 group. This indicated that a low PCL content could potentially facilitate the infiltration of the inflammatory cells. In the G5P5 and G3P7 groups, CD3- and CD68-positive cells were only observed in the outer and edge regions. The presence of continuous, homogenous cartilage blocks characterized by a continuous layer of undegraded scaffolds (<xref ref-type="fig" rid="F7">Figures 7D&#x2013;I</xref>, <xref ref-type="fig" rid="F8">Figures 8D&#x2013;I</xref>) was observed at the central region. This indicated that a high PCL content could potentially help prevent the infiltration of the inflammatory cells. The presence of a large number of CD3- and CD68-positive cells was observed in the layered undegraded scaffolds at the edges of the specimens belonging to the G3P7 group. The tissue integration levels (between the layered undegraded scaffolds) (<xref ref-type="fig" rid="F7">Figure&#x20;7I</xref>, <xref ref-type="fig" rid="F8">Figure&#x20;8I</xref>) observed, in this case, were lower than the tissue integration levels observed in the samples belonging to the G5P5 group (with better cartilage-like tissue integration between the layered undegraded scaffolds) (<xref ref-type="fig" rid="F7">Figure&#x20;7F</xref>, <xref ref-type="fig" rid="F8">Figure&#x20;8F</xref>). This indicated that a significantly high PCL content might not be favorable for the prevention of inflammatory cell infiltration. This can be attributed to the low extents of cartilage regeneration and tissue integration achieved.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Inflammatory reaction characterized by CD3 staining. The samples in the G7P3 group show small and sparse cartilage islands surrounded by abundant CD3-positive cells <bold>(A&#x2013;C)</bold>. In the G5P5 and G3P7 groups, CD3-positive cells are observed in the outer and edge regions but not in the central regions <bold>(D&#x2013;I)</bold>. Compared to the G5P5 group <bold>(F)</bold>, more CD3-positive cells are observed among layered undegraded scaffold in the edge regions of the G3P7 group <bold>(I)</bold>.</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g007.tif"/>
</fig>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Inflammatory reaction characterized by CD68 staining. The samples in the G7P3 group show small and sparse cartilage islands surrounded by abundant CD68-positive cells <bold>(A&#x2013;C)</bold>. In the G5P5 and G3P7 groups, CD68-positive cells are observed in the outer and edge regions but not in the central regions <bold>(D&#x2013;I)</bold>. More CD68-positive cells are observed among layered undegraded scaffolds in the edge regions of the G3P7 group <bold>(I)</bold> compared to the G5P5 group <bold>(F)</bold>.</p>
</caption>
<graphic xlink:href="fbioe-09-752677-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>4 Discussion</title>
<p>The subcutaneous environment of large animals is an immune environment that is similar to the environment of the human body. Successful cartilage construction realized in the subcutaneous environment of large animals can have important guiding significance in the field of clinical transformation. We have previously reported that the electrospun GT/PCL nanofiber membrane was a promising scaffold for cartilage regeneration. We had also observed that the GT/PCL membranes characterized by low PCL content promoted cartilage construction in a nude mouse model (<xref ref-type="bibr" rid="B35">Xue et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>). The results presented herein reveal that the membranes with different GT/PCL ratios can support the process of subcutaneous cartilage regeneration in an autologous swine model. The cartilage tissues formed in the samples belonging to the G5P5 group were more homogeneous than the cartilage tissues formed in the members of the other groups. The maximum cartilage formation area ratio, the minimum extent of fibrous tissue ingrowth, and the minimum extent of infiltration of the inflammatory cells were also observed in this case. These results indicated that the GT/PCL nanofiber membrane could serve as a good scaffold that could be used to support the process of subcutaneous cartilage regeneration in future clinical translation. An optimum GT/PCL ratio helped promote cartilage formation.</p>
<p>The scarcity of ideal scaffolds is one of the bottlenecks that restrict the clinical translation of cartilage regeneration technology. Many scaffolds are not suitable for subcutaneous cartilage regeneration in an immunocompetent large animal model, even though these scaffolds can be used to successfully generate cartilage <italic>in&#x20;vitro</italic> or in nude mouse models (<xref ref-type="bibr" rid="B2">Asawa et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B8">Dumont et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B11">Francesca et&#x20;al., 2018</xref>). The unsuitability of these scaffolds can be attributed to aggressive immune activities. We have previously reported that chondrocytes combined with the PGA/PLA scaffold could be used to successfully construct cartilage <italic>in&#x20;vitro</italic> or in nude mice. However, these could not be used to regenerate good-quality cartilage in the subcutaneous environment of large animals as severe inflammation response results in the rapid degradation of the PGA fiber (<xref ref-type="bibr" rid="B22">Liu et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B24">Luo et&#x20;al., 2013</xref>). Prolonged <italic>in&#x20;vitro</italic> pre-culture methods should be conducted (&#x3e;8&#xa0;weeks) to dissipate the degradation products before implantation (<xref ref-type="bibr" rid="B21">Liu et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B40">Zhou et&#x20;al., 2018</xref>) to realize satisfactory cartilage regeneration. However, a long-term <italic>in&#x20;vitro</italic> culture method is time-consuming and expensive. The process also increases the risk of contamination. The GT/PCL electrospun membrane used in the current study is composed of the naturally occurring GT and polymeric PCL. GT is an accepted biosafety scaffold that has been widely used to realize multiple tissue regeneration. However, poor mechanical strength and rapid degradation time severely restrict its application in the field of cartilage regeneration (<xref ref-type="bibr" rid="B16">Huang et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B1">Aldana and Abraham, 2017</xref>). PCL is characterized by adequate mechanical strength, high elasticity, and long degradation time and can complement the weaknesses of GT (<xref ref-type="bibr" rid="B34">Woodward et&#x20;al., 1985</xref>; <xref ref-type="bibr" rid="B26">Pham et&#x20;al., 2006</xref>). Importantly, PCL and GT are Food and Drug Administration (FDA)-approved non-immunogenic materials that exhibit good biocompatibility. Therefore, theoretically, the use of the GT/PCL membrane should result in the generation of less extent of immune responses in large animal models. As evidenced in the current study, the various GT/PCL membranes (differing in the GT to PCL ratios) could not easily cause the polarization of the macrophages <italic>in&#x20;vitro</italic>. This directly proved that the materials were characterized by low immunogenicity. Following the process of subcutaneous implantation, inflammatory cell infiltrations were observed in the samples belonging to the G5P5 group, even though an abundance of the layered undegraded scaffolds was observed in the surroundings. This also indicated the low immunogenicity of the GT/PCL membranes. The chondrocyte-GT/PCL constructs cultured <italic>in&#x20;vitro</italic> over 2&#xa0;weeks formed homogenous and mature cartilage-like tissues characterized by typical lacuna-like structures. Positive staining in GAG and collagen II was observed after 3 and 6&#xa0;weeks of subcutaneous implantation in the autologous swine model. This indicated that the GT/PCL membranes could serve as a promising scaffold to realize subcutaneous cartilage regeneration. The use of these membranes could significantly save the <italic>in&#x20;vitro</italic> culture time, reduce culture costs, and reduce the risk of contamination.</p>
<p>The quality of the engineered cartilage presented significant differences among the three groups varying in the GT/PCL ratio in the autologous swine model. It was also observed that the influence of the GT/PCL ratio on the efficiency of cartilage regeneration in the swine model did not agree with the influence exerted on the process of cartilage regeneration in a nude mouse model (<xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>). In some cases, opposite trends were observed. We had previously reported that the low-PCL-ratio group could be used to realize the best cartilage regeneration in nude mice. However, the results obtained by studying the autologous swine model indicate that in the presence of the low-PCL-ratio group, the worst cartilage regeneration was realized after 3 and 6&#xa0;weeks of subcutaneous implantation. A significant extent of infiltration of the inflammatory cells and high levels of ingrowth of fibrous tissues throughout the sample were observed in the samples belonging to the G7P3 group. It was speculated that the nonspecific inflammatory response caused by implantation trauma, changes in the membrane structure, and the rapid degradation of the scaffolds resulted in poor cartilage regeneration in the samples belonging to the G7P3 group. Although the GT/PCL membranes hardly triggered immune responses, the process of implantation could inevitably cause acute trauma and nonspecific inflammatory responses, resulting in the high extent of infiltration of the inflammatory cells and secretion of inflammatory factors. The rapid change in the structure of the membrane with the extent of degradation also contributed to the process. Histological analysis reveals that the membranes with different GT/PCL ratios exhibited a barrier effect that helped block the infiltration of the macrophages (<italic>in&#x20;vitro</italic>). The rapid degradation of the scaffold, attributable to the high GT content, resulted in the weakening of the barrier effect in the samples belonging to the G7P3 group. The barrier effect observed in this case was weaker than the barrier effect observed in the other two groups. The weakening was initiated on day 6. The GT/PCL membranes subjected to the process of subcutaneous implantation failed to retain their continuous layered structures and thus failed to block the infiltration of the inflammatory cells. It was also observed that the implanted samples cultured <italic>in&#x20;vitro</italic> over a period of 2&#xa0;weeks presented loose cartilage structures. This significantly facilitated the infiltration of the inflammatory cells toward the interior of the samples. As a result, the process of cartilage regeneration in the samples of the G7P3 group was significantly disrupted by the presence of inflammatory cells and factors. These results indicated that the GT/PCL membranes characterized by high GT contents could not promote the process of subcutaneous cartilage regeneration in a large animal&#x20;model.</p>
<p>It was also observed that a high PCL content significantly delayed the process of scaffold degradation in the samples belonging to the G5P5 and G3P7 groups. Thus, the GT/PCL membranes retained the continuous layered structures, and the cell barrier effect was also observed. Nanoscale micropores (the pore size was smaller than the cell size) were present on the continuous layered structures. The presence of these pores can potentially help block the infiltration of the inflammatory cells and macromolecule factors. They can also allow the free transportation of nutrients and metabolized products. These pores potentially impart anti-inflammatory effects to the electrospun nanofibrous membranes (<xref ref-type="bibr" rid="B31">Wang et&#x20;al., 2016</xref>). The results presented herein confirm the feasibility of the concept. In the samples belonging to the G5P5 and G3P7 groups, the CD3- and CD68-positive cells were only observed in the outer regions and edges of the samples. These cells were absent in the inner regions, indicating that the continuous layered structures formed an anti-inflammatory barrier that helped block the invasion of the inflammatory cells. The presence of continuous, homogenous, and stable cartilage was observed in the central region, indicating that the continuous undegraded GT/PCL membranes had no significant influence on the process of transportation of nutrients and metabolized products.</p>
<p>The results indicated that the GT/PCL membranes characterized by high PCL contents could better retain the continuous layered structures. The membranes helped block the infiltration of the inflammatory cells. This, in turn, helped enhance the quality of the engineered cartilage. It was also observed that a significantly high PCL content might not be favorable for the prevention of the process of inflammatory cell infiltration. The number of the CD3- and CD68-positive cells present in the layered undegraded scaffold at the edges of the samples belonging to the G3P7 group was higher than the number of the CD3- and CD68-positive cells present in the samples belonging to the G5P5 group. A relatively low extent of tissue integration (compared to the extent of tissue integration realized in the G5P5 group) between the layered undegraded scaffold was observed at the edges of the samples belonging to the G3P7 group. Better cartilage-like tissue integration was realized at the edge regions of the samples belonging to the G5P5 group. The low extent of tissue integration recorded for the G3P7 group characterized by a significantly high PCL content resulted in an increase in the extent of infiltration of the inflammatory cells. Better tissue integration in the G5P5 group was achieved under conditions of optimum PCL content. The infiltration of the inflammatory cells and factors could be blocked under these conditions. The poor extent of tissue integration observed in the G3P7 group can be potentially attributed to the hydrophilicity and mechanical strength of the high PCL-content material. We have previously reported that a high PCL content in the membranes hindered the process of early cartilage formation (<italic>in vivo</italic>) in 3-week-old nude mice (<xref ref-type="bibr" rid="B38">Zheng et&#x20;al., 2014</xref>). Therefore, only the GT/PCL membranes characterized by an optimum GT/PCL ratio could serve as a satisfactory scaffold for subcutaneous cartilage formation in a large animal&#x20;model.</p>
</sec>
<sec id="s5">
<title>5 Conclusion</title>
<p>Homogenous cartilage could be successfully regenerated in the subcutaneous environment of an autologous swine model using electrospun GT/PCL nanofibrous membranes and autologous auricular chondrocytes following 2&#x20;weeks of <italic>in&#x20;vitro</italic> culture. A sandwich construction strategy was followed to regenerate the cartilage. The samples characterized by an optimum GT/PCL ratio (GT: PCL &#x3d; 50:50) could be used to achieve efficient cartilage regeneration. The anti-inflammatory barrier of the nanofibrous membrane and the extent of tissue integration significantly influenced the process. The samples containing a large amount of GT (GT: PCL &#x3d; 70:30) could not be used for efficient cartilage formation as under these conditions, the anti-inflammatory barrier attributable to the rapid degradation of the scaffold weakened. A poor extent of tissue integration was realized under conditions of high PCL contents. Thus, the samples characterized by high PCL contents (GT: PCL &#x3d; 30:70) could not be used for effective cartilage regeneration at the edges. The results presented herein provide important information and a valuable model to realize effective subcutaneous cartilage regeneration in immunocompetent animals. The results can potentially help in the clinical translation of tissue-engineered cartilage.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>; further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the &#x201c;Guide for Care of Laboratory Animals&#x201d; formulated by the National Ministry of Science (2006).</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>RZ: Conceptualization, Methodology, Data curation, Formal analysis, Writing - Original Draft. XW: Methodology, Data Curation. JX: Data Curation, Formal analysis. LY: Data Curation, Formal analysis. GW and BY: Data Curation, HX and RZ: Conceptualization, Resources. MH and JC: Investigation, Resources. ZS: Conceptualization, Writing - Original Draft. YL: Conceptualization, Writing - Review and Editing. GZ: Conceptualization, Methodology, Writing - Review and Editing.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>The current research was supported by the National Key Research and Development Program of China (2017YFC1103900), the National Natural Science Foundation of China (81871502, 81974291, 81701843, 31700837, 81671837), the Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research (2019CXJQ01), the Program of Shanghai Academic/Technology Research Leader (19XD1431100), the Clinical Research Plan of SHDC (No. SHDC2020CR 2045B), and the Cross-disciplinary Research Fund of Shanghai Ninth People&#x2019;s Hospital, Shanghai JiaoTong University School of Medicine (JYJC201901, JYJC202105).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.752677/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2021.752677/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldana</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Abraham</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Current Advances in Electrospun Gelatin-Based Scaffolds for Tissue Engineering Applications</article-title>. <source>Int. J.&#x20;Pharmaceutics</source> <volume>523</volume>, <fpage>441</fpage>&#x2013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.09.044</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Komura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishizawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takazawa</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Early Stage Foreign Body Reaction against Biodegradable Polymer Scaffolds Affects Tissue Regeneration during the Autologous Transplantation of Tissue-Engineered Cartilage in the Canine Model</article-title>. <source>Cell Transpl.</source> <volume>21</volume>, <fpage>1431</fpage>&#x2013;<lpage>1442</lpage>. <pub-id pub-id-type="doi">10.3727/096368912x640574</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bateman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>N. S.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Retrospective Review of Augmentation Rhinoplasties Using Autologous Cartilage Grafts</article-title>. <source>J.&#x20;Laryngol. Otol.</source> <volume>114</volume>, <fpage>514</fpage>&#x2013;<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1258/0022215001906264</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bichara</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>O&#x27;Sullivan</surname>
<given-names>N.-A.</given-names>
</name>
<name>
<surname>Pomerantseva</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sundback</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Vacanti</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>The Tissue-Engineered Auricle: Past, Present, and Future</article-title>. <source>Tissue Eng. B: Rev.</source> <volume>18</volume>, <fpage>51</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2011.0326</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bichara</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Pomerantseva</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kulig</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Successful Creation of Tissue-Engineered Autologous Auricular Cartilage in an Immunocompetent Large Animal Model</article-title>. <source>Tissue Eng. A</source> <volume>20</volume>, <fpage>303</fpage>&#x2013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2013.0150</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brent</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Technical Advances in Ear Reconstruction with Autogenous Rib Cartilage Grafts: Personal Experience with 1200 Cases</article-title>. <source>Plast. Reconstr. Surg.</source> <volume>104</volume>, <fpage>319335</fpage>&#x2013;<lpage>334338</lpage>. <pub-id pub-id-type="doi">10.1097/00006534-199908000-00001</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bay</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ramakrishna</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Evaluation of Electrospun PCL/gelatin Nanofibrous Scaffold for Wound Healing and Layered Dermal Reconstitution&#x2606;</article-title>. <source>Acta Biomater.</source> <volume>3</volume>, <fpage>321</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2007.01.002</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumont</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>L. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Controlled Release Strategies for Modulating Immune Responses to Promote Tissue Regeneration</article-title>. <source>J.&#x20;Controlled Release</source> <volume>219</volume>, <fpage>155</fpage>&#x2013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2015.08.014</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farndale</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Sayers</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>A Direct Spectrophotometric Microassay for Sulfated Glycosaminoglycans in Cartilage Cultures</article-title>. <source>Connect. Tissue Res.</source> <volume>9</volume>, <fpage>247</fpage>&#x2013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.3109/03008208209160269</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Acetic-acid-mediated Miscibility toward Electrospinning Homogeneous Composite Nanofibers of GT/PCL</article-title>. <source>Biomacromolecules</source> <volume>13</volume>, <fpage>3917</fpage>&#x2013;<lpage>3925</lpage>. <pub-id pub-id-type="doi">10.1021/bm3009389</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francesca</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Manuela</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Christopher</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Guillermo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chiara</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Biomimetic Tissue Engineering: Tuning the Immune and Inflammatory Response to Implantable Biomaterials</article-title>. <source>Adv. Healthc. Mater.</source> <volume>7</volume>, <fpage>e1800490</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201800490</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulco</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Miot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Haug</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Barbero</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wixmerten</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Engineered Autologous Cartilage Tissue for Nasal Reconstruction after Tumour Resection: an Observational First-In-Human Trial</article-title>. <source>The Lancet</source> <volume>384</volume>, <fpage>337</fpage>&#x2013;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(14)60544-4</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J.&#x20;X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A sandwich Model for Engineering Cartilage with Acellular Cartilage Sheets and Chondrocytes</article-title>. <source>Biomaterials</source> <volume>32</volume>, <fpage>2265</fpage>&#x2013;<lpage>2273</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.11.078</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holness</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Molecular Cloning of CD68, a Human Macrophage Marker Related to Lysosomal Glycoproteins</article-title>. <source>Blood</source> <volume>81</volume>, <fpage>1607</fpage>&#x2013;<lpage>1613</lpage>. <pub-id pub-id-type="doi">10.1182/blood.v81.6.1607.bloodjournal8161607</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Athanasiou</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cell-based Tissue Engineering Strategies Used in the Clinical Repair of Articular Cartilage</article-title>. <source>Biomaterials</source> <volume>98</volume>, <fpage>1</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.04.018</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Z.-M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. Z.</given-names>
</name>
<name>
<surname>Ramakrishna</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>C. T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Electrospinning and Mechanical Characterization of Gelatin Nanofibers</article-title>. <source>Polymer</source> <volume>45</volume>, <fpage>5361</fpage>&#x2013;<lpage>5368</lpage>. <pub-id pub-id-type="doi">10.1016/j.polymer.2004.04.005</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bouma</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Boerman</surname>
<given-names>O. C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Incorporation of Stromal Cell-Derived Factor-1&#x3b1; in PCL/gelatin Electrospun Membranes for Guided Bone Regeneration</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>735</fpage>&#x2013;<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.10.016</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.-F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Turng</surname>
<given-names>L.-S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Electrospun Polycaprolactone/gelatin Composites with Enhanced Cell-Matrix Interactions as Blood Vessel Endothelial Layer Scaffolds</article-title>. <source>Mater. Sci. Eng. C</source> <volume>71</volume>, <fpage>901</fpage>&#x2013;<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2016.10.083</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanani</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Bahrami</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Review on Electrospun Nanofibers Scaffold and Biomedical Applications</article-title>. <source>Trends Biomater. Artif. Organs</source> <volume>24</volume>. </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>T. Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Use of Porous High-Density Polyethylene (Medpor) for Spreader or Extended Septal Graft in Rhinoplasty</article-title>. <source>Ann. Plast. Surg.</source> <volume>67</volume>, <fpage>464</fpage>&#x2013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1097/sap.0b013e3182045741</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Prolonged <italic>In Vitro</italic> Precultivation Alleviates post-implantation Inflammation and Promotes Stable Subcutaneous Cartilage Formation in a Goat Model</article-title>. <source>Biomed. Mater.</source> <volume>12</volume>, <fpage>015006</fpage>. <pub-id pub-id-type="doi">10.1088/1748-605X/12/1/015006</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>
<italic>In Vitro</italic> engineering of Human Ear-Shaped Cartilage Assisted with CAD/CAM Technology</article-title>. <source>Biomaterials</source> <volume>31</volume>, <fpage>2176</fpage>&#x2013;<lpage>2183</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.11.080</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Polycaprolactone Nanofibrous Mesh Reduces Foreign Body Reaction and Induces Adipose Flap Expansion in Tissue Engineering Chamber</article-title>. <source>Ijn</source> <volume>11</volume>, <fpage>6471</fpage>&#x2013;<lpage>6483</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.s114295</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Long-term Functional Reconstruction of Segmental Tracheal Defect by Pedicled Tissue-Engineered Trachea in Rabbits</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>3336</fpage>&#x2013;<lpage>3344</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.01.060</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nayyer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Esmaeili</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rippel</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Birchall</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>O&#x2bc;Toole</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Tissue Engineering</article-title>. <source>Plast. Reconstr. Surg.</source> <volume>129</volume>, <fpage>1123</fpage>&#x2013;<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1097/prs.0b013e31824a2c1c</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pham</surname>
<given-names>Q. P.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Mikos</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Electrospun Poly(&#x3b5;-Caprolactone) Microfiber and Multilayer Nanofiber/Microfiber Scaffolds: Characterization of Scaffolds and Measurement of Cellular Infiltration</article-title>. <source>Biomacromolecules</source> <volume>7</volume>, <fpage>2796</fpage>&#x2013;<lpage>2805</lpage>. <pub-id pub-id-type="doi">10.1021/bm060680j</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pomerantseva</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bichara</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cronce</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Cervantes</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Ear-Shaped Stable Auricular Cartilage Engineered from Extensively Expanded Chondrocytes in an Immunocompetent Experimental Animal Model</article-title>. <source>Tissue Eng. Part A</source> <volume>22</volume>, <fpage>197</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2015.0173</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Surface Modification of Nanofibrous Matrices via Layer-By-Layer Functionalized Silk Assembly for Mitigating the Foreign Body Reaction</article-title>. <source>Biomaterials</source> <volume>164</volume>, <fpage>22</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.02.038</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sterodimas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Faria</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Correa</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Pitanguy</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Tissue Engineering and Auricular Reconstruction: a Review</article-title>. <source>J.&#x20;Plast. Reconstr. Aesthet. Surg.</source> <volume>62</volume>, <fpage>447</fpage>&#x2013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjps.2008.11.046</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Dongen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krissansen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wolvers-Tettero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Comans-Bitter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Adriaansen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hooijkaas</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>1988</year>). <article-title>Cytoplasmic Expression of the CD3 Antigen as a Diagnostic Marker for Immature T-Cell Malignancies</article-title>. <source>Blood</source> <volume>71</volume>, <fpage>603</fpage>&#x2013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1182/blood.v71.3.603.bloodjournal713603</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>W.-D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vuletic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Overcoming Foreign-Body Reaction through Nanotopography: Biocompatibility and Immunoisolation Properties of a Nanofibrous Membrane</article-title>. <source>Biomaterials</source> <volume>102</volume>, <fpage>249</fpage>&#x2013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.06.028</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Harnessing Electrospun Nanofibers to Recapitulate Hierarchical Fibrous Structures of Meniscus</article-title>. <source>J.&#x20;Biomed. Mater. Res.</source> <volume>109</volume>, <fpage>201</fpage>&#x2013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.34692</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiggenhauser</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Schantz</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Rotter</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Cartilage Engineering in Reconstructive Surgery: Auricular, Nasal and Tracheal Engineering from a Surgical Perspective</article-title>. <source>Regenerative Med.</source> <volume>12</volume>, <fpage>303</fpage>&#x2013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.2217/rme-2016-0160</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodward</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Brewer</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Moatamed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schindler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pitt</surname>
<given-names>C. G.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>The Intracellular Degradation of Poly(?-Caprolactone)</article-title>. <source>J.&#x20;Biomed. Mater. Res.</source> <volume>19</volume>, <fpage>437</fpage>&#x2013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.820190408</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Engineering Ear-Shaped Cartilage Using Electrospun Fibrous Membranes of Gelatin/polycaprolactone</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>2624</fpage>&#x2013;<lpage>2631</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.12.011</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>The Impact of Low Levels of Collagen IX and Pyridinoline on the Mechanical Properties of <italic>In Vitro</italic> Engineered Cartilage</article-title>. <source>Biomaterials</source> <volume>30</volume>, <fpage>814</fpage>&#x2013;<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2008.10.042</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>E. I.</given-names>
</name>
<name>
<surname>Mathur</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Decellularized Tracheal Matrix Scaffold for Tracheal Tissue Engineering</article-title>. <source>Plast. Reconstr. Surg.</source> <volume>132</volume>, <fpage>549e</fpage>&#x2013;<lpage>559e</lpage>. <pub-id pub-id-type="doi">10.1097/prs.0b013e3182a013fc</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The Influence of Gelatin/PCL Ratio and 3-D Construct Shape of Electrospun Membranes on Cartilage Regeneration</article-title>. <source>Biomaterials</source> <volume>35</volume>, <fpage>152</fpage>&#x2013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.09.082</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The "Yin and Yang" of Immunomodulatory Magnesium-Enriched Graphene Oxide Nanoscrolls Decorated Biomimetic Scaffolds in Promoting Bone Regeneration</article-title>. <source>Adv. Healthc. Mater.</source> <volume>10</volume>, <fpage>2000631</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.202000631</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>
<italic>In Vitro</italic> Regeneration of Patient-specific Ear-Shaped Cartilage and its First Clinical Application for Auricular Reconstruction</article-title>. <source>EBioMedicine</source> <volume>28</volume>, <fpage>287</fpage>&#x2013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2018.01.011</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>